Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Alvimopan price, strengths & recalls

Alvimopan has no weekly pharmacy acquisition cost. 4 manufacturers make it. Its official label last changed on October 29, 2026.

Generic
No weekly pricePharmacy acquisition costs aren't published for this drug - usually because it's given in clinics or hospitals.

Alvimopan price by strength

What pharmacies pay for each strength and form this week, for the usual package. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
12 mg capsuleNot priced this week

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
No ongoing recallsNone on record

What did you pay for alvimopan? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedOctober 29, 2026
Version3 of 3
EffectiveOct 26, 2026
Read the label

ALVIMOPAN CAPSULES. These highlights do not include all the information needed to use ALVIMOPAN CAPSULES safely and effectively. See full prescribing information for ALVIMOPAN CAPSULES. ALVIMOPAN capsules, for oral use Initial U.S. Approval: 2008

This drug has a boxed warning

WARNING: POTENTIAL RISK OF MYOCARDIAL INFARCTION WITH LONG-TERM USE: FOR SHORT-TERM HOSPITAL USE ONLY

There was a greater incidence of myocardial infarction in alvimopan-treated patients compared to placebo-treated patients in a 12-month clinical trial, although a causal relationship has not been established. In short-term trials with alvimopan, no increased risk of myocardial infarction was observed

[see Warnings and Precautions (5.1)]

.

Because of the potential risk of myocardial infarction with long-term use, alvimopan is available only through a restricted program for short-term use (15 doses) under a Risk Evaluation and Mitigation Strategy (REMS) called the Alvimopan REMS Program

[see Warnings and Precautions (5.1,

5.2)]

.

WARNING: POTENTIAL RISK OF MYOCARDIAL INFARCTION WITH LONG-TERM USE: FOR SHORT-TERM HOSPITAL USE ONLY

See full prescribing information for complete boxed warning.

Increased incidence of myocardial infarction was seen in a clinical trial of patients taking alvimopan for long-term use. (

5.1)

Alvimopan capsules are available only through a restricted program for short-term use (15 doses) called the Alvimopan REMS Program. (

5.1,

5.2)

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Generic makers
3 approved generic applications on the market

Alvimopan questions

Is alvimopan in shortage?

No shortage is reported for alvimopan right now. We check the national shortage list every day.

Has alvimopan been recalled?

No recalls are on record for alvimopan.

When did the alvimopan label last change?

The official label was last updated on October 29, 2026 (version 3). See what changed.

Talk about alvimopan

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.